載入...
Are evidence standards different for genomic- vs. clinical-based precision medicine? - A quantitative analysis of individualized warfarin therapy
Evidence requirements for implementation of precision medicine (PM), whether informed by genomic or clinical data, are not well defined. Evidence requirements are driven by uncertainty and its attendant consequences; these aspects can be quantified by a novel technique in health economics, value of...
Na minha lista:
| 發表在: | Clin Pharmacol Ther |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5552446/ https://ncbi.nlm.nih.gov/pubmed/28187492 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.663 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|